Modern approaches to the treatment of patients with functional constipation
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 4
Abstract
Objective — to study the efficacy and tolerability of the Lactofor® complex (Ananta Medicare) in outpatients with the verified diagnosis of functional constipation (FC) according to Rome criteria IV. Materials and methods. The study involved 30 outpatients with FC aged 33- 59 years (mean age 47.6 ± 5.9 years), with an average disease duration of 14.9 ± 4.8 years, who were treated with the Lactofor® complex during 28 days: the first 5 days — 2 sachets per day, followed by 1 — 2 sachets per day. The treatment effectiveness was assessed by the dynamics of defecation frequency, the feces according the Bristol scale, the assessment of pain syndrome and flatulence on the visual analog scale, the hydrogen breath test (HBT) with lactulose. Patients’ status and quality of life were assessed with the use of specialized patient questionnaires (PAC-SYM — Patient Assessment of Constipation Symptoms and PAC-QoL — Patient Assessment of Quality of Life questionnaire). Results. The administration of Lactofor® complex to patients with FC promoted the increase ofbowel movements’ frequency (after 28 days of observation, 100 % of patients reported daily bowel movement, lack of tension and incomplete emptying) and normalization of stool character, which was confirmed by an increase in stool scores according to the Bristol scale (2.07 ± 0.4 vs 3.42 ± 0.25; p < 0.05). The effects of Lactofor® complex on the reduction of FC symptomshas been established, in particular, a decrease in the intensity and severity of flatulence in 1.9 times (p < 0.01), as well as painful abdominal syndrome in 2.1 times (p < 0.01). There was also a clear positive trend in PAC-SYM and quality of life (PAC-QoL) indicators. Reduction of HBT at all intervals of the test confirmed the positive effect of the Lactofor® complex on reducing the severity of the bacterial overgrowth syndrome. Conclusions. The administrationof Lactofor® complex to patients with FC promoted the increase of bowel movements’ frequency, normalization of stool character, it resulted in the reduction ofintensity and severity of flatulence, painful abdominal syndrome, as well as improvement of the quality of life.
Authors and Affiliations
I. M. Skrypnyk, O. F. Gopko, I. G. Kryvoruchko
Keywords
Related Articles
- EP ID EP670162
- DOI 10.30978/MG-2019-4-85
- Views 149
- Downloads 0
Deep cystic gastritis: literature review and clinical case
The article presents the overview of recent literature data on a rare variant of chronic gastritis, deep cystic gastritis (gastritis cysticaprofunda). In the most cases, this disease is diagnosed histologically in patien...
Complex therapy of non-alcoholic fatty liver disease in combination with the syndrome of intestinal bacterial overgrowth
Objective — to study the effects of three-month administration of the combined cytoprotector L-Betargin on the lipid and carbohydrate metabolism, biochemical markers of liver damage, the degree of its steatosis and fibro...
Basal and postprandial levels of ghrelin and the nature of eating behaviour in patients with irritable bowel syndrome with constipation against the background of various degrees of obesity
Objective — to study the basal and postprandial serum levels of ghrelin, its association with types of eating behaviour and the appearance of constipation in patients with irritable bowel syndrome against the background...
The mechanisms of development of irritable bowel syndrome and treatment of abdominal pain in the light of Rome IV criteria
Objective — to assess the clinical efficacy of Capsumen in patients with irritable bowel syndrome (IBS) with pain syndrome. Materials and methods. The investigation involved 17 patients (7 women and 10 men aged 19 to 52...
Clinical case of the Wasserman false positive test at the autoimmune hepatitis combined with antiphospholipid syndrome
The article briefly describes treponemal and non-treponemal serological tests that are used to diagnose syphilis, as well as the causes of false positive results of these tests. A clinical observation has been presented...